Craft

Vivos Therapeutics

Stock Price

$2.5

2024-07-19

Market Capitalization

$8.3 M

2024-07-19

Revenue

$13.8 M

FY, 2023

Vivos Therapeutics Summary

Company Summary

Overview
Vivos Therapeutics is a company that specializes in the treatment of sleep and breathing disorders. It offers Vivos System, a non-surgical, non-invasive, non-pharmaceutical solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).
Type
Public
Status
Active
Founded
2013
HQ
Highlands Ranch, CO, US | view all locations
Website
https://vivos.com/
Cybersecurity rating
Sectors

Key People

  • Dave Singh

    Dave Singh, Founder, Director and Chief Medical Officer

  • Edward Loew

    Edward Loew, Investor Relations Officer, Head of Capital Markets

  • Nick Degenarro

    Nick Degenarro, Senior Vice President, Medical Integration Division

Operating MetricsView all

Patients

15K

Q3, 2020

Dentists Served

1.2K

Q3, 2020

LocationsView all

1 location detected

  • Highlands Ranch, CO HQ

    United States

    9135 S Ridgeline Blvd #100

Vivos Therapeutics Financials

Summary Financials

Revenue (Q1, 2024)
$3.4M
Gross profit (Q1, 2024)
$1.9M
Net income (Q1, 2024)
($3.8M)
Cash (Q1, 2024)
$2.6M
EBIT (Q1, 2024)
($3.8M)
Enterprise value
$6.6M

Footer menu